aslan pharmaceuticals pte ltd
ASLAN & CSL To Develop Asthma Treatment
ASLAN acquires license for CSL334, an anti-IL13 receptor monoclonal antibody for the treatment of asthma.
ASLAN Pharmaceuticals Opens Taiwan Office
Biotech company ASLAN Pharmaceuticals Pte Ltd, which is headquartered in Singapore, has opened a new office in Taipei, Taiwan.
ASLAN Pharmaceuticals Secures US$22m In Series B Financing
ASLAN Pharmaceuticals has raised US$22 million after hosting a second round of financing with Cenova Ventures.
ASLAN’s Pan-HER Inhibitor Shows Positive Data In Gastric Cancer PhII Study
ASLAN Pharma announced this week positive data with ASLAN001 in a gastric cancer Phase II study.
ASLAN Pharma To Develop Bristol-Myers Squibb’s BMS-777607 Compound
ASLAN Pharma and Bristol-Myers Squibb will co-develop an investigational small molecule inhibitor of the MET receptor tyrosine kinase for treatment of solid tumors.








